University of Cape Town South Africa | Cape Town
3
Overview: 

Plant Produced Biologics Cape Bio Pharms (CBP) is an exciting company to commercialise the biotechnology developed by the Biopharming Research Unit at UCT. CBP's aim is to develop a world-class commercial-scale capability in RSA for the production of patented plant-produced enzymes, diagnostic reagents, recombinant proteins and vaccines for animal health. UCT and CBP is currently seeking funding to bring the first basket of products to market.

What is the technology owner looking for? E.g. collaboration, investment, sales, etc.
Distribution Investment Other
The Technology Readiness Level of the available technology. For more information on the Technology Readiness Levels, please follow the link: Technology Readiness Levels
Technology readiness level 7
Share
Copyright © Innovation Bridge 2020 All rights reserved.